Erythrocyte-derived epoxyeicosatrienoic acids

被引:8
|
作者
Jiang, Houli [1 ]
机构
[1] New York Univ Coll, Dept Pharmacol, Valhalla, NY 10595 USA
关键词
erythrocyte; red blood cells; epoxyeicosatrienoic acids; ATP; purinergic receptors; phospholipase A2; release;
D O I
10.1016/j.prostaglandins.2006.05.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Red blood cells (RBCs) are reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs) that can be released. The sources of EET release from RBCs include direct synthesis from arachidonic acid, peroxidation of phospholipids and EETs esterified into cellular phospholipids. The release of EETs from RBCs can be through cytosolic phospholipase A2 (PLA(2)), secretory PLA(2) and other, responses associated with ATP release from RBCs. The erythrocyte ATP, purinergic receptors, ATP-binding cassette transporters, PLA2 and cytoskeleton rearrangement may all participate in EET release in the microcirculatory deformation of RBCs. EETs are vasodilatory and are candidate endothelium-derived hyperpolarizing factors. Due to the anti-hypertensive, fibrinolytic, and anti-thrombotic properties of EETs, their release from RBCs is replete with implications for the control of circulation and theological characteristics of the circulating blood. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 50 条
  • [1] Design of erythrocyte-derived carriers for bioimaging applications
    Lai, Wing -Fu
    Zhang, Dahong
    Wong, Wing-Tak
    TRENDS IN BIOTECHNOLOGY, 2023, 41 (02) : 228 - 241
  • [2] Erythrocyte-derived liposomes for the treatment of inflammatory diseases
    Olival, A.
    Vieira, S. F.
    Goncalves, V. M. F.
    Cunha, C.
    Tiritan, M. E.
    Carvalho, A.
    Reis, R. L.
    Ferreira, H.
    Neves, N. M.
    JOURNAL OF DRUG TARGETING, 2022, 30 (08) : 873 - 883
  • [3] Erythrocyte-derived ectosomes have immunosuppressive properties
    Sadallah, Salima
    Eken, Ceylan
    Schifferli, Juerg A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (05) : 1316 - 1325
  • [4] Erythrocyte-derived mitochondria take to the lupus stage
    Lepelley, Alice
    Crow, Yanick J.
    CELL METABOLISM, 2021, 33 (09) : 1723 - 1725
  • [5] Erythrocyte-derived drug delivery systems in cancer therapy
    Yishen Mao
    Caifeng Zou
    Yongjian Jiang
    Deliang Fu
    Chinese Chemical Letters, 2021, 32 (03) : 990 - 998
  • [6] Magnetic Nanosensor for Detection and Profiling of Erythrocyte-Derived Microvesicles
    Rho, Junsung
    Chung, Jaehoon
    Im, Hyungsoon
    Liong, Monty
    Shao, Huilin
    Castro, Cesar M.
    Weissleder, Ralph
    Lee, Hakho
    ACS NANO, 2013, 7 (12) : 11227 - 11233
  • [7] Erythrocyte-derived depressing factor: a novel cardiovascular player?
    Selvetella, G
    Maffei, A
    Lembo, G
    JOURNAL OF HYPERTENSION, 2003, 21 (06) : 1087 - 1088
  • [8] Action mechanisms of a new erythrocyte-derived depressing factor
    Wen, YY
    Zhang, XC
    Xu, XR
    Zhao, GQ
    Wan, F
    CHINESE SCIENCE BULLETIN, 2000, 45 (23): : 2113 - 2118
  • [9] Action mechanisms of a new erythrocyte-derived depressing factor
    WEN Yunyi
    Chinese Science Bulletin, 2000, (23) : 2113 - 2118
  • [10] Characteristics of erythrocyte-derived microvesicles and its relation with atherosclerosis
    Li, Kai-Yin
    Zheng, Lei
    Wang, Qian
    Hu, Yan-Wei
    ATHEROSCLEROSIS, 2016, 255 : 140 - 144